Preventing and managing pelvic inflammatory disease: key questions, practices, and evidence.
Clinicians play a pivotal role in protecting women from pelvic inflammatory disease (PID), one of the most prevalent and serious diseases affecting women of reproductive age. This article examines PID prevention and management by critically addressing five questions: (1) What are the key risk factors for PID? (2) What are the principal microorganisms involved in PID? (3) What are the appropriate diagnostic criteria for PID? (4) What are the best treatment regimens for PID? and (5) What are the effective strategies for preventing PID? In addressing each of these questions, the quality of available evidence and recommended practice is discussed and gaps in the evidence are highlighted.
Washington
E
E
Department of Obstetrics, Gynecology, and Reproductive Sciences, School of Medicine, University of California, San Francisco 94143-0132, USA.
Berg
A O
AO
D000553:Ambulatory Care; D000890:Anti-Infective Agents / Q000008:administration & dosage; D005260:Female; D006760:Hospitalization; D006801:Humans; D000292:Pelvic Inflammatory Disease / Q000175:diagnosis / Q000382:microbiology / Q000517:prevention & control* / Q000628:therapy*; D012307:Risk Factors
D000890:Anti-Infective Agents